Join
Live feed
·
INSIDERFilingvia Quantisnow
Ovid Therapeutics Inc. logo

SEC Form 4: Tardio Jason sold $37,290 worth of shares (17,344 units at $2.15), closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
OVID· Ovid Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OVID (Ovid Therapeutics Inc.) and more on Quantisnow.